Fundraising FoxOnya
Ebbw Vale, GB · 1 known investors
Find your way into Onya
Sign up to see every warm intro you have to Onya
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Onya team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ONYA Therapeutics develops investigational pharmaceutical treatments for chronic and acute wounds, using a patented silicone-based patch that stabilises and delivers a well-characterised active compound to modulate wound exudate and restart healing. Its lead programme OTX-PP01 targets chronic wounds such as diabetic foot ulcers, with additional variants planned for battlefield trauma and cancer-related wounds.</parameter> <parameter name="founders">[{"full_name": "Thomas Hafner", "title": "CEO & Founder"}]
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- ONYA LIMITED
- Company number
- 08487555
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 15 Apr 2013
- Registered office
- Dirleton House, Forest Row, East Sussex, RH18 5AA
- Nature of business (SIC)
- 46450 — Wholesale of perfume and cosmetics47750 — Retail sale of cosmetic and toilet articles in specialised stores
- Accounts
- last made up to 30 Apr 2025 · next due 31 Jan 2027
- Confirmation statement
- last made up to 30 Jun 2026 · next due 14 Jul 2027
Current officers · 1
- Julie Mary Aitchison — director, appointed 15 Apr 2013
Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Onya do?
- ONYA Therapeutics develops investigational pharmaceutical treatments for chronic and acute wounds, using a patented silicone-based patch that stabilises and delivers a well-characterised active compound to modulate wound exudate and restart healing. Its lead programme OTX-PP01 targets chronic wounds such as diabetic foot ulcers, with additional variants planned for battlefield trauma and cancer-related wounds.</parameter> <parameter name="founders">[{"full_name": "Thomas Hafner", "title": "CEO & Founder"}]
- Who are Onya's investors?
- Onya's investors include South East Angels.
- Where is Onya headquartered?
- Onya is headquartered in Ebbw Vale, GB.